add

Tuesday, February 26, 2019

Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

No comments:

Post a Comment

Samsung Galaxy XCover 7 Pro, Galaxy Tab Active 5 Pro With Snapdragon 7s Gen 3 SoC Launched

Samsung has unveiled the Galaxy XCover 7 Pro alongside the Galaxy Tab Active 5 Pro in select global markets. Both devices carry the Snapdrag...